• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与“冒烟型”多发性骨髓瘤相关的系统性肥大细胞增多症。

Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.

作者信息

Zanelli Magda, Ricci Stefano, Zizzo Maurizio, Sanguedolce Francesca, De Giorgi Federica, Palicelli Andrea, Martino Giovanni, Ascani Stefano

机构信息

Pathology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.

Surgical Oncology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.

出版信息

Diagnostics (Basel). 2021 Jan 7;11(1):88. doi: 10.3390/diagnostics11010088.

DOI:10.3390/diagnostics11010088
PMID:33430341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7825792/
Abstract

A 79-year-old woman presented with a long history of peripheral eosinophilia. Previous right hemicolectomy for colonic polyposis was reported. Laboratory tests were notable for mild macrocitic anaemia and eosinophilia. β2 microglobulin and serum tryptase levels were elevated. Serum immunofixation revealed IgA/kappa monoclonal protein. Bence-Jones protein was positive. Bone marrow (BM) biopsy revealed the coexistence of two neoplastic components. Cohesive clusters of bland-looking, spindle-shaped mast cells, representing 20% of marrow cellularity, were close to aggregates of mature plasma cells occupying 40% of marrow cellularity. Molecular analysis on marrow aspirate demonstrated KIT D816V mutation, TET2 mutation, monoallelic deletion of TP53/17p13 and trisomy of ATM/11q23. A bone density study revealed mild osteoporosis. Full skeletal X-rays and magnetic resonance imaging (MRI) of spine and hips showed multiple, small rarefaction areas and an old L1-L2 fracture, both ascribed to osteoporosis. The association of systemic mastocytosis (SM) and multiple myeloma (MM) is very uncommon. The coexistence of SM with MM placed our patient in the SM with associated clonal haematological non-mast-cell lineage disease (SM-AHN) subtype. Midostaurin therapy was started.

摘要

一名79岁女性,有长期外周血嗜酸性粒细胞增多病史。据报告曾因结肠息肉病行右半结肠切除术。实验室检查显示轻度大细胞性贫血和嗜酸性粒细胞增多。β2微球蛋白和血清类胰蛋白酶水平升高。血清免疫固定电泳显示IgA/κ单克隆蛋白。本周氏蛋白阳性。骨髓活检显示存在两种肿瘤成分。外观温和的梭形肥大细胞紧密聚集,占骨髓细胞的20%,靠近占骨髓细胞40%的成熟浆细胞聚集区。骨髓穿刺液的分子分析显示存在KIT D816V突变、TET2突变、TP53/17p13单等位基因缺失以及ATM/11q23三体。骨密度研究显示轻度骨质疏松。全脊柱X线及脊柱和髋部磁共振成像(MRI)显示多个小的骨质稀疏区以及一处陈旧性L1-L2骨折,均归因于骨质疏松。系统性肥大细胞增多症(SM)与多发性骨髓瘤(MM)的关联非常罕见。该患者同时存在SM和MM,属于伴有相关克隆性血液非肥大细胞谱系疾病的系统性肥大细胞增多症(SM-AHN)亚型。开始使用米哚妥林治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/4a46fc39047e/diagnostics-11-00088-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/a2a4ef209a99/diagnostics-11-00088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/156b44a5d96f/diagnostics-11-00088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/92b6ad8e4999/diagnostics-11-00088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/acded0f9c5a2/diagnostics-11-00088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/4a46fc39047e/diagnostics-11-00088-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/a2a4ef209a99/diagnostics-11-00088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/156b44a5d96f/diagnostics-11-00088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/92b6ad8e4999/diagnostics-11-00088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/acded0f9c5a2/diagnostics-11-00088-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4280/7825792/4a46fc39047e/diagnostics-11-00088-g005.jpg

相似文献

1
Systemic Mastocytosis Associated with "Smoldering" Multiple Myeloma.与“冒烟型”多发性骨髓瘤相关的系统性肥大细胞增多症。
Diagnostics (Basel). 2021 Jan 7;11(1):88. doi: 10.3390/diagnostics11010088.
2
Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.霍奇金淋巴瘤是系统性肥大细胞增多症中一种罕见的克隆性血液非肥大细胞疾病。
Diagn Pathol. 2015 Mar 14;10:5. doi: 10.1186/s13000-015-0235-y.
3
An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL).一例罕见的系统性肥大细胞增多症合并慢性淋巴细胞白血病(SM-CLL)病例。
J Clin Pathol. 2006 Mar;59(3):264-8. doi: 10.1136/jcp.2005.026989.
4
Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.血清类胰蛋白酶与惰性系统性肥大细胞增多症成人的 KIT D816V 突变负担相关。
Eur J Haematol. 2013 Aug;91(2):106-11. doi: 10.1111/ejh.12128. Epub 2013 Jun 28.
5
Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.系统性肥大细胞增多症中骨髓组织学集中评估的影响
Eur J Clin Invest. 2016 May;46(5):392-7. doi: 10.1111/eci.12607. Epub 2016 Mar 21.
6
Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge.伴有相关克隆性血液非肥大细胞谱系疾病的系统性肥大细胞增多症:一项组织病理学挑战。
J Clin Pathol. 2004 Jun;57(6):604-8. doi: 10.1136/jcp.2003.014860.
7
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.KIT D816V 突变负担与惰性系统性肥大细胞增多症的临床表现无关。
J Allergy Clin Immunol. 2013 Sep;132(3):723-728. doi: 10.1016/j.jaci.2013.02.019. Epub 2013 Apr 12.
8
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.化疗和达沙替尼可使伴有KIT D816V的系统性肥大细胞增多症合并急性髓系白血病获得长期血液学和分子学缓解。
Leuk Res. 2009 May;33(5):735-41. doi: 10.1016/j.leukres.2008.09.027. Epub 2008 Nov 4.
9
A case of bone marrow mastocytosis associated with multiple myeloma.
Ann Hematol. 1998 Mar-Apr;76(3-4):167-74. doi: 10.1007/s002770050382.
10
Acute myeloid leukaemia with t(8;21) associated with "occult" mastocytosis. Report of an unusual case and review of the literature.伴“隐匿性”肥大细胞增多症的急性髓系白血病伴t(8;21)。1例罕见病例报告及文献复习
J Clin Pathol. 2004 Mar;57(3):324-8. doi: 10.1136/jcp.2003.012864.

引用本文的文献

1
Mast Cell Leukemia: An Update with a Practical Review.肥大细胞白血病:最新进展与实用综述
Cancers (Basel). 2023 Mar 8;15(6):1664. doi: 10.3390/cancers15061664.
2
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review (Part 6): Correlation of PD-L1 Expression with the Status of Mismatch Repair System, , , and Other Genes.关于前列腺癌中PD-L1表达我们需要了解什么?一项系统文献综述(第6部分):PD-L1表达与错配修复系统状态及其他基因的相关性
Biomedicines. 2022 Jan 22;10(2):236. doi: 10.3390/biomedicines10020236.
3
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 7: PD-L1 Expression in Liquid Biopsy.

本文引用的文献

1
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.肥大细胞增多症国际预后评分系统(IPSM):一项回顾性队列研究。
Lancet Haematol. 2019 Dec;6(12):e638-e649. doi: 10.1016/S2352-3026(19)30166-8. Epub 2019 Oct 31.
2
Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management.成人系统性肥大细胞增生症:诊断、危险分层和治疗的 2019 年更新。
Am J Hematol. 2019 Mar;94(3):363-377. doi: 10.1002/ajh.25371. Epub 2019 Jan 2.
3
Systemic mastocytosis in association with plasma cell dyscrasias: report of a case and review of the literature.
关于前列腺癌中PD-L1表达我们需要了解什么?一项系统文献综述。第7部分:液体活检中的PD-L1表达
J Pers Med. 2021 Dec 6;11(12):1312. doi: 10.3390/jpm11121312.
4
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables.我们需要了解前列腺癌中 PD-L1 表达的哪些方面?系统文献综述。第 1 部分:重点关注免疫组织化学结果,并讨论分析前和解释变量。
Cells. 2021 Nov 14;10(11):3166. doi: 10.3390/cells10113166.
5
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic Correlations.前列腺癌中 PD-L1 表达我们需要了解什么?系统文献回顾。第 2 部分:临床-病理相关性。
Cells. 2021 Nov 14;10(11):3165. doi: 10.3390/cells10113165.
6
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.我们需要了解前列腺癌中 PD-L1 表达的哪些信息?系统文献回顾。第 3 部分:PD-L1、细胞内信号通路和肿瘤微环境。
Int J Mol Sci. 2021 Nov 15;22(22):12330. doi: 10.3390/ijms222212330.
7
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.关于前列腺癌中程序性死亡受体配体1(PD-L1)表达我们需要了解什么?一项系统文献综述。第5部分:PD-L1的表观遗传调控
Int J Mol Sci. 2021 Nov 15;22(22):12314. doi: 10.3390/ijms222212314.
8
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 4: Experimental Treatments in Pre-Clinical Studies (Cell Lines and Mouse Models).我们需要了解前列腺癌中 PD-L1 表达的哪些信息?系统文献回顾。第 4 部分:临床前研究中的实验治疗(细胞系和小鼠模型)。
Int J Mol Sci. 2021 Nov 14;22(22):12297. doi: 10.3390/ijms222212297.
9
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2).EB病毒驱动的淋巴组织增生性疾病及胃肠道淋巴瘤:具有共同特征的一系列实体疾病(第2部分)
Cancers (Basel). 2021 Sep 8;13(18):4527. doi: 10.3390/cancers13184527.
10
Gastrointestinal Manifestations in Systemic Mastocytosis: The Need of a Multidisciplinary Approach.系统性肥大细胞增多症的胃肠道表现:多学科方法的必要性。
Cancers (Basel). 2021 Jul 1;13(13):3316. doi: 10.3390/cancers13133316.
Leuk Res. 2009 Jun;33(6):856-9. doi: 10.1016/j.leukres.2008.11.010. Epub 2009 Jan 14.
4
A case of bone marrow mastocytosis associated with multiple myeloma.
Ann Hematol. 1998 Mar-Apr;76(3-4):167-74. doi: 10.1007/s002770050382.
5
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.白细胞介素6(一种有效的骨髓瘤细胞生长因子)的血清水平,可反映浆细胞异常增殖性疾病的疾病严重程度。
J Clin Invest. 1989 Dec;84(6):2008-11. doi: 10.1172/JCI114392.